Table 3.
Postoperative morbidity and perioperative chemotherapy administration data categorized by age group
| Overall (n=119) | Age ≥80 (n=31) | Age <80 (n=88) | p | |
|---|---|---|---|---|
| 30-day perioperative morbidity, n (%) | 0.29 | |||
| CD 0 | 34 (28%) | 8 (26%) | 26 (29%) | |
| CD 1–2 (minor complications) | 55 (46%) | 16 (52%) | 39 (44%) | |
| CD 3–4 (major complications) | 24 (20%) | 4 (13%) | 20 (23%) | 0.30 |
| CD 5 (mortality) | 6 (5%) | 3 (10%) | 3 (3%) | 0.18 |
| Perioperative chemotherapy*, n (%) | 33 (28%) | 4 (13%) | 29 (33%) | 0.03 |
| Neoadjuvant | 19 (16%) | 3 (10%) | 16 (18%) | 0.39 |
| Adjuvant | 14 (12%) | 1 (3%) | 13 (15%) | 0.11 |
| Toxicity grade 3–4**, n (%) | 2 (50%) | 9 (31%) | 0.58 | |
| Pre-chemotherapy eGFR†, median (IQR) | 72 (62–102) | 98 (59–143) | 72 (64–101) | 0.63 |
*
None of the patients received both neoadjuvant and adjuvant treatments.
**
Percentages represent the relative proportion out of patients who received chemotherapy.
†
Units of mL/min/1.73 m2.
CD: Clavien-Dindo; eGFR: estimated glomerular filtration rate.